1. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor.
- Author
-
Kobayashi H, Yoshida R, Kanada Y, Fukuda Y, Yagyu T, Inagaki K, Kondo T, Kurita N, Suzuki M, Kanayama N, and Terao T
- Subjects
- Adult, Cells, Cultured, Down-Regulation, Enzyme Activation drug effects, Enzyme Inhibitors pharmacology, Female, Gingiva cytology, Humans, Interleukin-1 antagonists & inhibitors, Interleukin-6 antagonists & inhibitors, MAP Kinase Signaling System drug effects, Mitogen-Activated Protein Kinase 1 antagonists & inhibitors, Mitogen-Activated Protein Kinase 3 antagonists & inhibitors, Mitogen-Activated Protein Kinases drug effects, NF-kappa B antagonists & inhibitors, Up-Regulation drug effects, p38 Mitogen-Activated Protein Kinases antagonists & inhibitors, Fibroblasts drug effects, Gingiva drug effects, Inflammation Mediators pharmacology, Lipopolysaccharides pharmacology, Trypsin Inhibitor, Kunitz Soybean pharmacology, Trypsin Inhibitors pharmacology, Tumor Necrosis Factor-alpha antagonists & inhibitors
- Abstract
Background: Human bikunin, a Kunitz-type trypsin inhibitor, inhibits inflammation by down-regulating the expression of proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) in tumor cells and inflammatory cells., Objectives: We analyzed the effect of a soybean-derived Kunitz trypsin inhibitor (KTI) on TNF-alpha production in human gingival fibroblasts stimulated by lipopolysaccharide (LPS), an inflammatory inducer., Material and Methods: Mitogen-activated protein kinase (MAPK) activation and cytokine levels were monitored using western blot and a specific enzyme-linked immunosorbent assay (ELISA)., Results: Here, we show (i) a soybean KTI abrogates LPS-induced up-regulation of TNF-alpha mRNA and protein expression in a dose-dependent manner in gingival fibroblasts, (ii) KTI also blocks the induction of TNF-alpha target molecules interleukin-1beta (IL-1beta) and IL-6 proteins, (iii) inhibition by KTI of TNF-alpha induction correlates with the suppressive capacity of extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 signaling pathways, implicating repressed ERK1/2 and p38 signalings in the inhibition, and (iv) pretreatment of cells with KTI blocked LPS-induced nuclear factor kappaB (NFkappaB) activation., Conclusion: Our results indicate that KTI inhibits LPS-induced up-regulation of cytokine expression possibly through suppression of ERK1/2 and p38 kinase-mediated NFkappaB activation. These findings may identify anti-inflammatory properties of KTI at the level of gingival fibroblasts and may be relevant to the use of KTI in modulating inflammation, including periodontal disease.
- Published
- 2005
- Full Text
- View/download PDF